Springer set to publish official journal of the Controlled Release Society. STM publisher Springer has announced that it will publish a new international, peer-reviewed journal Drug Delivery and Translational Research, starting February 2011. Focusing exclusively on translational aspects of drug delivery, the bi-monthly journal seeks to provide a unique forum for publication of high-quality research. The journal is the official journal of the Controlled Release Society (CRS). Dr. Vinod Labhasetwar of the Cleveland Clinic, Ohio, USA, will be the editor-in-chief. He is supported by an international editorial board with renowned experts from research centers and hospitals.
Drug Delivery and Translational Research will publish research on such topics as designing and developing novel drug delivery systems, with a focus on their application to disease conditions; preclinical and clinical data related to drug delivery systems; short-term and long-term biocompatibility of drug delivery systems; nanomedicine, and other state-of-the-art technologies. In addition to original full-length papers, reviews, and editorial commentary, the journal will include brief communications, notice of future meetings and announcements pertaining to activities of the Society.
Drug Delivery and Translational Research will be published on Springer's online platform SpringerLink including Online First, Cross Reference Linking, and Alert services. The journal will be provided to all members of the CRS as a benefit of membership.
